DCGI Approves Dr Reddy’s Zytorvi for Esophageal Cancer
Dr Reddy's Laboratories said on Wednesday that India's drug regulator has cleared its cancer immunotherapy drug Zytorvi for a new and much larger patient group, giving doctors another weapon against…
Impressive Mobile First Website Builder
Ready for Core Web Vitals, Support for Elementor, With 1000+ Options Allows to Create Any Imaginable Website. It is the Perfect Choice for Professional Publishers.
